83 related articles for article (PubMed ID: 191336)
1. [Hypersensitivity to tetracosactide].
Ligumski M; Kletter-Chemo D; Penchas S
Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336
[No Abstract] [Full Text] [Related]
2. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
Usobiaga JL
Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
[No Abstract] [Full Text] [Related]
3. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].
Kawai M; Maekawa N
Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495
[No Abstract] [Full Text] [Related]
4. [Discussion of a case of dyschromia].
Nicolay M; Piot V
Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
[No Abstract] [Full Text] [Related]
5. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
Cret L; David M; Macabéo V; Frédérich A; Jeune M
Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427
[No Abstract] [Full Text] [Related]
6. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients].
Béal JL; Freysz M; Honnart D; Wilkening M
Therapie; 1983; 38(5):569-71. PubMed ID: 6322376
[No Abstract] [Full Text] [Related]
7. [Synthetic ACTH in theumatic diseases: (author's transl)].
Hieber F
MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
[TBL] [Abstract][Full Text] [Related]
8. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
Roldaan AC; de Jong C
Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
[No Abstract] [Full Text] [Related]
9. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
Kropp R
Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of rheumatoid arthritis in children with tetracosactide beta-24].
Popova-Kiprova Z; Zvetkova V; Karakashoff A; Mihailova E
Wien Med Wochenschr; 1974 Apr; 124(14):221-5. PubMed ID: 4363301
[No Abstract] [Full Text] [Related]
12. Letter: Allergic reactions to tetracosactrin.
Mohr PD
Br Med J; 1975 Oct; 4(5989):162. PubMed ID: 172182
[No Abstract] [Full Text] [Related]
13. [Synacthen retard].
Ménégol B; Brard M
Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
[No Abstract] [Full Text] [Related]
14. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
Bordier C; Flechet ML; Thomine E; Lauret P
Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
[No Abstract] [Full Text] [Related]
15. [Tetracosactide in the acute phase of cerebrovascular accidents].
Cornaert P
Lille Med; 1980; 25(7):384-6. PubMed ID: 6253756
[No Abstract] [Full Text] [Related]
16. [Use of Cortrosyn Depot in dermatology].
Aussems J
Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
[No Abstract] [Full Text] [Related]
17. [Analgesic action of tetracosactide in chronic pain syndromes].
Procacci P; Zoppi M; Maresca M; Sereni E
Clin Ter; 1981 Sep; 98(6):643-6. PubMed ID: 6169484
[No Abstract] [Full Text] [Related]
18. Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.
Brombacher PJ; Maesen FP; Gijzen AH
Lancet; 1975 Feb; 1(7904):456. PubMed ID: 48646
[No Abstract] [Full Text] [Related]
19. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
Harnack K; Flegel P
Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
[No Abstract] [Full Text] [Related]
20. Chronic pancreatitis after therapy with synthetic ACTH.
Trancoso VN; Ramos JS; Barreiras J; Reis B
Am J Gastroenterol; 1984 Oct; 79(10):769-72. PubMed ID: 6091442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
